Aitiologic Emerges from Stealth Mode

Aitiologic, an Austrian precision diagnostics startup that has officially emerged from stealth mode, backed by over €2.5 million in funding.

Building on patented technology and an exclusive IP license from Siemens Healthineers, Aitiologic develops a simple blood test to identify both, the underlying cause as well as the location of disease. The company’s unique liquid biopsy approach, which combines genetic and epigenetic DNA testing with the aitios® platform for cloud-based interpretation, is set to significantly enhance non-invasive prenatal and oncology testing.